ACR ACRES Commercial Realty Corp.

NYSE
$12.53

ACRES Faces First Post-Internalization Test as Stock Trades Far Below Book Value

ACRES Commercial Realty heads into its September-quarter report with a striking disconnect. Management spent the last call describing a company on the verge of transformation, with an internalization deal approved by roughly 99% of voting shareholders and a lending pipeline the CEO called the strongest he has seen. The market has responded by cutting the stock by a third. At $11.95, shares trade well under half of the $26.76 GAAP book value reported at the end of June. The report due after the close on November 4 is the first real chance to show whether that discount reflects a misunderstanding or a warning.

The Street is not asking for much. Consensus calls for earnings of $0.07 a share on revenue of $12.6 million, a 92.7% drop from the year-ago $0.96 and a 40.1% decline in revenue from $21.0 million. That is a sharp contraction on paper. Some of it likely reflects the transition management flagged, as the company shifts from a pure REIT balance sheet to a model that includes fee income from managing outside capital. Management asked investors for patience with the accounting, and this quarter will show how messy the reported numbers get. The company gave no formal guidance beyond reaffirming its target of $500 million in net REIT portfolio growth for 2026, so the consensus figure is the main benchmark.

The hurdle is low because management has already said more one-time costs are coming. The June quarter absorbed $5.1 million of transaction expenses, $4 million of accelerated compensation and about $1 million of accelerated deferred debt costs. Those charges pushed earnings available for distribution to a loss of $0.74 a share, against roughly $0.14 excluding the one-offs. If the deal closed during the quarter, the more useful number will be underlying earnings power once these items are stripped out. A figure at or above that $0.14 run rate would support the idea that the core lending business is intact. A lower one would suggest the noise is hiding real erosion.

Portfolio direction matters just as much. The loan book shrank by $74.9 million last quarter, with payoffs of $92.7 million far outpacing $17.8 million of new fundings. That reversed a strong March quarter and fits poorly with a $500 million growth target and a pipeline described as better than ever. A rebound in originations would validate the confident tone. Another quarter of net runoff would make the growth goal look increasingly hard to reach. Net interest income, which rose to $10.5 million on the full-quarter benefit of the FL4 securitization, needs to hold up as well.

Credit is the other pressure point. The weighted-average risk rating slipped to 2.6 from 2.5, and the company added $1.7 million to CECL reserves after a release the prior quarter. With liquidity also down to $83 million, further reserve building or rating drift would feed the bearish case. Progress on the two remaining foreclosed properties, including a hotel held for sale since 2022, would help.

Sentiment has soured noticeably, moving to 45.8% bearish from 17.2% heading into the last report. The stock sits far below its 200-day moving average of $17.20 and near the bottom of its post-earnings range of $9.91 to $17.98, well beneath the prior quarter's $15.61 to $23.15 band. That pessimism lowers the bar, but it also means investors want hard numbers rather than illustrative cases. The central question is whether ACRES can give a clear first look at pro forma fee earnings, against the $48 million to $73 million illustrative range, alongside a stable book value and a growing loan book. If it does, the deep discount to book looks hard to justify. If it does not, the market's skepticism will look earned.

← Back to ACR news